STERIS plc (NYSE:STE) has been exhibiting mixed performance recently. In the recent earnings call for Q4 2024, it failed to meet earnings per share expectations but excelled on the revenue front. A number of trading days saw the company's stocks perform robustly against competitors. Furthermore, several investment management firms, including International Assets Investment Management LLC and Locust Wood Capital Advisers LLC, have increased their stakes in STERIS. Victory Capital Management also purchased a considerable number of shares. Despite matching Q4 earnings estimates and surpassing Q1 estimates, the stock has seen some underperformance. Notable investment groups continue to hold significant positions in the company. StockNews.com upgraded its rating to 'Buy' despite some mixed responses to its fundamentals. In the end, it is imperative to remember that the firm was able to register strong Q3 fiscal results with noticeable growth in revenue and earnings.
Steris Plc STE News Analytics from Thu, 06 Dec 2018 08:00:00 GMT to Sun, 12 May 2024 09:13:50 GMT -
Rating 0
- Innovation -5
- Information 7
- Rumor 1
